Creative Biolabs provides professional-grade formulation and aseptic filling for complex antibody-drug conjugates. We offer a high-containment environment equipped with automated isolator technology and advanced lyophilization capabilities. By partnering with us, clients gain access to a specialized technical team that ensures the preservation of the drug-to-antibody ratio (DAR), minimizes de-conjugation risks, and delivers stable, high-purity materials ready for rigorous laboratory evaluation and further research development.
Antibody-drug conjugates (ADCs) are the next frontier of oncology therapies and combine the targeting power of monoclonal antibodies with the efficacy of cytotoxic payloads. This dual-action system is the next step in cancer treatment, where drugs are released into cancer cells without damaging healthy tissues. However, the manufacture of ADCs involves several steps that need to be done carefully and skilled at each step. ADC fill and finish service is one of the most important of these steps. This step provides the final formulation, sterility, and stability of ADC drugs according to the highest regulatory requirements. Creative Biolabs is the leader in this area and boasts of the latest facilities, quality assurance, and regulatory compliance to help clients provide safe and effective ADCs.
Fill and finish of ADC involves filling and sterilizing the final drug into the correct container by strict quality control. This is done with the utmost accuracy using the most advanced technology and under current Good Manufacturing Practices (cGMP) at Creative Biolabs.
Creative Biolabs specializes in both liquid and lyophilized ADC formulations, ensuring stability and performance even under challenging conditions. Our expertise includes advanced freeze-drying protocols for heat-sensitive ADCs, guaranteeing long shelf life and consistent efficacy.
Our cutting-edge facilities are tailored for ADC production, featuring advanced clean rooms and sterile containment systems. Whether it's small-batch preclinical studies or large-scale clinical requirements, we ensure safety, sterility, and precision at every stage.
Choose from a range of container configurations (2 mL to 50 mL), validated through rigorous stability testing. Our versatile solutions are designed to meet diverse needs, from clinical trials to commercial-scale production, offering unmatched reliability.
We understand the unique needs of ADCs. Through comprehensive stability studies and customized approaches, Creative Biolabs ensures your ADC achieves peak performance, providing a seamless path from development to market-ready success.
Discover how we can help - Get a quote today.
We monitor the filling path for physical stress and utilize low-binding materials to prevent selective payload loss, ensuring the final conjugate maintains its ratio.
Yes, our specialized facilities use advanced restricted access barrier systems and negative-pressure isolators to ensure safe, contained handling of highly potent research molecules.
Creative Biolabs offers a fully integrated pipeline for ADC development, ensuring seamless progression from discovery to final drug product.
Utilizing phage display platforms, Creative Biolabs identifies high-affinity monoclonal antibodies targeting specific antigens, laying the foundation for successful ADCs.
Learn More →Through lysine and cysteine conjugation, the company achieves efficient attachment of cytotoxic payloads while preserving antibody integrity.
Learn More →Designing customized linkers and payloads ensures optimal pharmacokinetic and pharmacodynamic profiles.
Learn More →Using advanced analytical techniques, Creative Biolabs validates ADCs for structural integrity and functional activity.
Learn More →With senior Ph.D. level scientists and extensive experience in the field of ADC discovery and development, Creative Biolabs now offers ADC manufacturing, formulation development, fill and finish services to facilitate your ADC program and push the progress forward. For more detailed information, please feel free to contact us.